Thomas Pangerl

557 total citations
14 papers, 446 citations indexed

About

Thomas Pangerl is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Thomas Pangerl has authored 14 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Thomas Pangerl's work include Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Thomas Pangerl is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Thomas Pangerl collaborates with scholars based in Austria, Italy and China. Thomas Pangerl's co-authors include Irene Virgolini, M. Leimer, Claudia Bischof, Markus Peck‐Radosavljevic, P. Angelberger, Robert Dudczak, Gerhard Hamilton, Amir Kurtaran, Klaus Kaserer and Peter Smith‐Jones and has published in prestigious journals such as Gastroenterology, JNCI Journal of the National Cancer Institute and Endocrinology.

In The Last Decade

Thomas Pangerl

14 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Pangerl Austria	11	284	220	162	141	61	14	446
Gregory D. Espenan United States	10	408 1.4×	357 1.6×	157 1.0×	287 2.0×	56 0.9×	16	574
L Ausema Netherlands	4	382 1.3×	280 1.3×	158 1.0×	246 1.7×	46 0.8×	8	563
C. Angerstein Germany	8	191 0.7×	183 0.8×	290 1.8×	43 0.3×	93 1.5×	14	432
Stefano Papi Italy	10	179 0.6×	193 0.9×	182 1.1×	146 1.0×	49 0.8×	25	446
Arthur van Gameren Netherlands	11	447 1.6×	380 1.7×	435 2.7×	211 1.5×	79 1.3×	14	711
J. D. Minna United States	2	142 0.5×	215 1.0×	40 0.2×	90 0.6×	72 1.2×	3	348
Tilmann Schumacher Switzerland	4	432 1.5×	358 1.6×	212 1.3×	271 1.9×	109 1.8×	6	601
Esther I. van Vliet Netherlands	7	379 1.3×	338 1.5×	139 0.9×	275 2.0×	47 0.8×	9	496
Sibylle Haraida Germany	8	202 0.7×	54 0.2×	151 0.9×	20 0.1×	103 1.7×	12	528
Timon Vandamme Belgium	11	268 0.9×	322 1.5×	22 0.1×	150 1.1×	42 0.7×	46	455

Countries citing papers authored by Thomas Pangerl

Since Specialization

Citations

This map shows the geographic impact of Thomas Pangerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pangerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pangerl more than expected).

Fields of papers citing papers by Thomas Pangerl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pangerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pangerl. The network helps show where Thomas Pangerl may publish in the future.

Co-authorship network of co-authors of Thomas Pangerl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Pangerl. A scholar is included among the top collaborators of Thomas Pangerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Pangerl. Thomas Pangerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

El‐Gazzar, Ahmed, Paul Perco, Eva Eckelhart, et al.. (2010). Natural Immunity Enhances the Activity of a DR5 Agonistic Antibody and Carboplatin in the Treatment of Ovarian Cancer. Molecular Cancer Therapeutics. 9(4). 1007–1018. 16 indexed citations

Perco, Paul, Cornelia Sax, Thomas Pangerl, et al.. (2008). Linking the ovarian cancer transcriptome and immunome. BMC Systems Biology. 2(1). 2–2. 17 indexed citations

Virgolini, Irene, M. Leimer, Shuren Li, et al.. (2002). Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs. Current Pharmaceutical Design. 8(20). 1781–1807. 74 indexed citations

Virgolini, Irene, M. Leimer, Shuren Li, et al.. (2001). New trends in peptide receptor radioligands.. PubMed. 45(2). 153–9. 37 indexed citations

Fueger, Barbara J., Gerhard Hamilton, Markus Raderer, et al.. (2001). Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells.. PubMed. 42(12). 1856–62. 28 indexed citations

Petkov, Ventzislav, Thomas Pangerl, Markus Raderer, et al.. (2001). 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.. PubMed. 42(9). 1309–15. 32 indexed citations

Virgolini, Irene, M. Leimer, Thomas Pangerl, et al.. (2000). New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.. PubMed. 44(1). 50–8. 18 indexed citations

Raderer, Markus, Julia Valencak, Franz Pfeffel, et al.. (1999). Somatostatin Receptor Expression in Primary Gastric Versus Nongastric Extranodal B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type. JNCI Journal of the National Cancer Institute. 91(8). 716–718. 14 indexed citations

Smith‐Jones, Peter, Claudia Bischof, M. Leimer, et al.. (1999). DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1. Endocrinology. 140(11). 5136–5148. 69 indexed citations

10.

Raderer, Markus, Julia Valencak, Werner Scheithauer, et al.. (1998). Expression of Human Somatostatin Receptor Subtype 3 in Pancreatic Cancer In Vitro and In Vivo. JNCI Journal of the National Cancer Institute. 90(21). 1666–1668. 10 indexed citations

11.

Kurtaran, Amir, Thomas Pangerl, Christian Scheuba, et al.. (1998). VISUALIZATION OF INTESTINAL SPLENOSIS BY SOMATOSTATIN RECEPTOR SCINTIGRAPHY. The American Journal of Gastroenterology. 93(8). 1375–1376. 4 indexed citations

12.

Peck‐Radosavljevic, Markus, M. Leimer, Claudia Bischof, et al.. (1998). The somatostatin receptor (SSTR) subtype 3 ACTS as an acceptor of vasocative intestinal peptide (VIP). Gastroenterology. 114. A1172–A1172. 3 indexed citations

13.

Virgolini, Irene, M. Leimer, Hirsch Handmaker, et al.. (1998). Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829.. PubMed. 58(9). 1850–9. 95 indexed citations

14.

Virgolini, Irene, Thomas Pangerl, Claudia Bischof, Peter Smith‐Jones, & Markus Peck‐Radosavljevic. (1997). Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer?. European Journal of Clinical Investigation. 27(8). 645–647. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact